• Amplifying Our Shared Mission in the Media: June Media Mentions

    At the Alliance for Clinical Trials in Oncology, our media relations efforts are designed to alert the public about the vital work happening across our network. When we share stories about groundbreaking clinical trials, scientific milestones, or investigator achievements, we are showcasing the real-world progress you help make possible. These media features serve a crucial…

  • AFT Study Finds Some Prostate Cancer Drugs Related to More Cognitive Decline

    A new randomized Alliance Foundation Trials (AFT) clinical study found that men with advanced prostate cancer taking the hormone therapy medication darolutamide had less cognitive decline compared to men taking enzalutamide. According to results from the ARACOG (AFT-47) phase II trial, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2026,…

Categories


Alliance Committee


Browse by Year